- CVS Health maintains its quarterly dividend at $0.665 per share, offering stability for income-focused investors.
- Analyst consensus implies a significant upside potential for CVS Health, with an average target price of $78.80.
- GuruFocus estimates suggest a potential 27.12% upside from the current stock price based on fair value assessments.
CVS Health (CVS, Financial) has announced that its quarterly dividend will remain steady at $0.665 per share. This payout is scheduled for August 1, with an ex-dividend date of July 22, benefiting shareholders recorded by that date. This consistency in dividends underscores CVS Health's commitment to returning value to its shareholders, offering reliability amidst market fluctuations.
Wall Street Analysts Forecast
According to projections from 24 analysts, the average one-year target price for CVS Health Corp (CVS, Financial) is $78.80, highlighting a potential upside of 17.20% from the current stock price of $67.24. The range of estimates reflects a high target of $95.00 and a low of $70.00. For a detailed breakdown of these forecasts, visit the CVS Health Corp (CVS) Forecast page.
Furthermore, consensus from 29 brokerage firms places CVS Health Corp's (CVS, Financial) average recommendation at 2.1, signaling an "Outperform" status. This rating is on a scale where 1 indicates a Strong Buy, and 5 suggests a Sell.
Insight from GuruFocus: GF Value
From a valuation perspective, GuruFocus estimates the GF Value for CVS Health Corp (CVS, Financial) in one year to be $85.47. This estimation implies a potential upside of 27.12% from the current price of $67.235. GF Value represents GuruFocus' comprehensive assessment of a stock's fair trading value. This metric considers historical trading multiples, past business growth, and future performance projections. For an in-depth analysis, visit the CVS Health Corp (CVS) Summary page.
Also check out: (Free Trial)
